Programme

08:30 Registration opens
09:00 Exhibition and Partnering throughout the day
10:00 General Assembly of Swiss Biotech Association
(by invitation only)
  Plenary Session
11:00 Welcome Address
Keynote: Vasant Narasimhan, CEO, Novartis AG
Pablo Umaña, Head Cancer Immunotherapy Discovery, Roche Glycart AG
Frank Mathias, CEO, Rentschler Biopharma SE
Presentation of the Swiss Biotech Report, Jürg Zürcher, Partner, Ernst & Young
12:30 Lunch sponsored by
13:30 Parallel tracks in the afternoon
 

1a: Analyst and Investor

Company presentations:

  • Santhera Pharmaceuticals
  • Newron Pharmaceuticals
  • Addex Therapeutics 
  • Idorsia
  • Molecular Partners
  • InnoMedica 



 

1b: International R&D cooperation Forum with a focus on UK

presented by:

2: Emerging Companies


presented by:

Company presentations:

  • Topadur Pharma
  • Vaxxilon
  • Therachon
  • Heptares Therapeutics
  • Cellestia Biotech
  • SynDermix AG
  • Legacy Health Care
  • CDR-Life AG
  • DXC RT 
  • Lunaphore Technologies 
  • SimplicityBio
  • Biognosys
  • Sophia GENETICS
  • certus molecular diagnostics

3: Market Place

presented by:

Funding Biotech companies
– discuss with the experts

  • KPMG AG
  • SIX Swiss Exchange
  • Zürcher Kantonalbank, Bank
  • Homburger AG, Law
  • BioMed Partners AG, Investor
  • Basilea Pharmaceutica AG, listed company
  • Venture Valuation, valuation company
 
17:00 Swiss Biotech Associations's 20th anniversary celebration with aperó riche and launch of Swiss Biotech Success Stories
19:00 End